{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:43Z","timestamp":1786120243146,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/cad.0b013e328349c7bb","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T18:36:17Z","timestamp":1317753377000},"page":"1020-1023","source":"Crossref","is-referenced-by-count":28,"title":["Wound healing and catheter thrombosis after implantable venous access device placement in 266 breast cancers treated with bevacizumab therapy"],"prefix":"10.1097","volume":"22","author":[{"given":"Ir\u00e8ne","family":"Kriegel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H.","family":"Cottu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Fourchotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Fromantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krassen","family":"Kirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pelloquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Esteve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remy J.","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl 1","key":"R1-9-20210203","first-page":"S12","article-title":"The safety of perioperative bevacizumab use.","volume":"147","author":"Mariani","year":"2010","journal-title":"J Chir (Paris)"},{"key":"R2-9-20210203","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S1470-2045(02)00905-1","article-title":"Totally implantable venous-access ports: local problems and extravasation injury.","volume":"3","author":"Kurul","year":"2002","journal-title":"Lancet Oncol"},{"key":"R3-9-20210203","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1470-2045(09)70341-9","article-title":"Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care.","volume":"11","author":"Bose","year":"2010","journal-title":"Lancet Oncol"},{"key":"R4-9-20210203","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00520-008-0498-x","article-title":"It appears to be safe to start chemotherapy on the day of implantation through subcutaneous venous port catheters in inpatient setting.","volume":"17","author":"Ozdemir","year":"2009","journal-title":"Support Care Cancer"},{"key":"R5-9-20210203","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00520-004-0607-4","article-title":"Cutaneous bacterial colonization, modalities of chemotherapeutic infusion, and catheter-related bloodstream infection in totally implanted venous access devices.","volume":"12","author":"Laurenzi","year":"2004","journal-title":"Support Care Cancer"},{"key":"R6-9-20210203","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jvir.2009.01.022","article-title":"Wound dehiscence or failure to heal following venous access port placement in patients receiving bevacizumab therapy.","volume":"20","author":"Zawacki","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"R7-9-20210203","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jvir.2008.12.124","article-title":"Wound healing complications following Mediport placement in patients treated with bevacizumab Abstract no 140.","volume":"20","author":"Fong","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"R9-9-20210203","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/CAD.0b013e3282f2c063","article-title":"Subcutaneous implantable venous access device erosion through the skin in patients treated with anti-vascular endothelial growth factor therapy; a case series.","volume":"19","author":"Almahanna","year":"2008","journal-title":"Anti-cancer Drugs"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e328349c7bb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:21:13Z","timestamp":1786047673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-201111000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":8,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e328349c7bb","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}